Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -13.4 % |
3 Month Return | -5.65 % |
1 Year Return | + 13.81 % |
Market Stats | |
Previous Close | ₹585.15 |
Open | ₹585.55 |
Volume | 6.86L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹5,322.47Cr |
P/E Ratio | 23.33 |
PEG Ratio | 5.48 |
Market Cap | ₹5,322.47 Cr |
P/B Ratio | 2.43 |
EPS | 23.93 |
Dividend Yield | 0.69 |
Sector | Pharmaceuticals |
ROE | 13.11 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹5,322.47 Cr | 20.75% | 0.57 | ₹216 Cr | ₹1,852 Cr | |
NA | ₹5,044.92 Cr | 65.41% | 0.52 | -₹71 Cr | ₹1,704 Cr | |
NA | ₹2,549.73 Cr | 83.05% | 0.56 | -₹15 Cr | ₹180 Cr | |
NA | ₹712.10 Cr | 199.49% | 0.91 | ₹55 Cr | ₹575 Cr | |
BUY | ₹7,153.68 Cr | 1547.17% | 0.55 | ₹95 Cr | ₹819 Cr |
Organisation | Aarti Pharmalabs Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Aarti Pharmalabs Ltd
Aarti Pharmalabs Stock Downgraded Amid Declining Results - 06 Jan, 2025
Aarti Pharmalabs Faces Regulatory Closure at Vapi Plant - 03 Jan, 2025
Aarti Pharmalabs Gains from Stake Acquisition and Strong Performance - 27 Dec, 2024
Promoters Sell Stake; Abakkus Acquires in Aarti Pharmalabs - 26 Dec, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 7.38% to 8.64% in Dec 2024 quarter
Retail Holding Up
Retail Investor have increased holdings from 35.16% to 36.33% in Dec 2024 quarter
Promoter Holding Down
Promoters have decreased holdings from 46.10% to 44.66% in Dec 2024 quarter
Profit Down
Netprofit is down for the last 3 quarters, 65.25 Cr → 54.62 Cr (in ₹), with an average decrease of 8.3% per quarter
Price Dip
In the last 7 days, AARTIPHARM stock has moved down by -8.4%
MF Holding Down
Mutual Funds have decreased holdings from 4.93% to 3.93% in Dec 2024 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 557.71 Cr → 462.51 Cr (in ₹), with an average decrease of 17.1% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 44.66% | ||
Foreign Institutions | 8.64% | 17.15 | |
Mutual Funds | 3.93% | ||
Retail Investors | 36.33% | 3.33 | |
Others | 6.44% | 0.07 |
Aarti Pharmalabs Ltd in the last 5 years
Lowest (11.23x)
February 2, 2023
Today (23.33x)
January 29, 2025
Industry (51.91x)
January 29, 2025
Highest (28.14x)
August 29, 2024
Aarti Pharmalabs Ltd’s net profit jumped 5.44% since last year same period to ₹54.62Cr in the Q2 2024-2025. On a quarterly growth basis, Aarti Pharmalabs Ltd has generated -1.5% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Aarti Pharmalabs Ltd has declared dividend of ₹1 - translating a dividend yield of 0.51%.
Read More about DividendsBearish
Neutral
Bullish
Aarti Pharmalabs Ltd is currently in a Bearish trading position according to technical analysis indicators.
Aarti Pharmalabs Ltd share price today stands at ₹587.3, Open: ₹585.55, Previous Close: ₹585.15, High: ₹599.8, Low: ₹581.2, 52 Week High: ₹721.7, 52 Week Low: ₹399.55.
Aarti Pharmalabs Ltd is listed on NSE
Aarti Pharmalabs Ltd is listed on BSE
Today's traded volume of Aarti Pharmalabs Ltd(AARTIPHARM) is 6.86L.
Today's market capitalisation of Aarti Pharmalabs Ltd(AARTIPHARM) is ₹5322.47Cr.
Aarti Pharmalabs Ltd (AARTIPHARM) share price is ₹587.3. It is down -18.62% from its 52 Week High price of ₹721.7
Aarti Pharmalabs Ltd (AARTIPHARM) share price is ₹587.3. It is up 46.99% from its 52 Week Low price of ₹399.55
PE Ratio of Aarti Pharmalabs Ltd is 23.33
PE ratio = Aarti Pharmalabs Ltd Market price per share / Aarti Pharmalabs Ltd Earnings per share